ArticleDiscover nano2026
Development of resveratrol-loaded hollow mesoporous silica enhances mechanical performance and biocompatibility of dental resin cement.
Article in Discover nano, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
objectivesThis work aims to develop a novel filler system by using resveratrol-loaded hollow mesoporous silica (HMS) to enhance the mechanical properties and reduce cytotoxicity of dental resin cement. MATERIALS &
methodsHMS was synthesised via an ammonia-catalysed sol-gel process. Resveratrol (Res) was encapsulated by HMS to obtain Res@HMS. Res@HMS was characterised via transmission electron microscopy, dynamic light scattering, nitrogen adsorption/desorption measurements, fourier transform infrared spectroscopy and thermogravimetric analysis. An experimental resin cement containing Res@HMS was prepared. The mechanical properties of resin cement were measured, including flexural strength, elastic modulus and Shore hardness. The in vitro cytotoxicity of resin cement was evaluated via CCK8, lactate dehydrogenase assay and reactive oxygen species measurement.
resultsA Res@HMS filler system with hollow mesoporous structure and the ability to encapsulate large amounts of resveratrol was successfully synthesised. This experimental resin cement modified by Res@HMS exhibited remarkable mechanical properties, especially against thermocycling ageing. The introduction of Res@HMS effectively protected human gingival fibroblasts against resin monomer-induced cytotoxicity.
conclusionRes@HMS can serve as a versatile modifier to optimise dental resin cement. This modification can preserve the long-term mechanical properties of dental cement and also reduce resin monomer-induced cytotoxicity. CLINICAL SIGNIFICANCE: The effective integration of mesoporous nanoparticles with plant extracts offers a novel filler that promises to balance the mechanical properties and cytotoxicity of resin cement, paving the way for developing a new generation of dental restorative materials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.